| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Renalytix PLC
Renalytix PLC
LSE:RENX
Renalytix PLC
Total Equity
Renalytix PLC
Total Equity Peer Comparison
CRW
COG
IUG
INS
EMIS
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Renalytix PLC
LSE:RENX
|
Total Equity
$18.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Total Equity
$324.3m
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
23%
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Total Equity
£1.3m
|
CAGR 3-Years
182%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-5%
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Total Equity
£9.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Instem PLC
LSE:INS
|
Total Equity
£53.4m
|
CAGR 3-Years
47%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Total Equity
£132.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
See Also
What is Renalytix PLC's Total Equity?
Total Equity
18.5m
USD
Based on the financial report for Jun 30, 2023, Renalytix PLC's Total Equity amounts to 18.5m USD.
What is Renalytix PLC's Total Equity growth rate?
Total Equity CAGR 3Y
-20%
Over the last year, the Total Equity growth was -57%. The average annual Total Equity growth rates for Renalytix PLC have been -20% over the past three years .
You don't have any saved screeners yet
